drugset / Trial / NCT05944887

Intravenous Lidocaine to Reduce Propofol Consumption During Gastroscopy.

NCT05944887 ↗

Completed 46 enrolled Erasme University Hospital
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The goal of this clinical trial is to assess if intravenous administration of linisol reduce the propofol consumption and the sides effects of sedation during gastroscopy in healthy patients (ASA 1 and 2 patients). Prior to propofol sedation, participants will receive either an intravenous bolus of linisol (1.5 mg/kg) = treated group or placebo = control group. After the gastroscopy, patients will be asked to complete a satisfaction questionnaire

Timeline

Start
2023-07-21
Primary completion
2023-08-21
Completion
2023-08-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 1.5 mg/kg Intravenous
Comparator Propofol Small molecule — Intravenous

Indications

No indication recorded.